Our Leadership Team | bluebird bio
Our Leadership Team | bluebird bio
bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies - Pharmaceutical Technology
bluebird bio | LinkedIn
Press Release
Roche's Spark Therapeutics, bluebird resolve suit on sickle cell disease 'Spark' campaign | Seeking Alpha
Stephen Dicker - Senior Director - bluebird bio | LinkedIn
bluebird bio Office Photos | Glassdoor
Bluebird Bio $BLUE : r/HellsTradingFloor
Bluebird Bio still in thick of sickle cell race, as updated data allay safety concerns
Bluebird Bio tabs Joseph Vittiglio as chief business and legal officer
Blue Matter Breakfast Club - Nick Leschly, CEO of bluebird bio
Untitled
bluebird bio to Present at the 37th Annual J.P. Morgan Healthcare Conference | Business Wire
Contact Us | bluebird bio
Gene Therapy Could See Revival With Bluebird Drugs at FDA Panel - Bloomberg
In the Boardroom
bluebird bio provides update on 2seventy bio spin-off - PMLiVE
Our Leadership Team | bluebird bio
bluebird bio Announces EU Conditional Marketing Authorization for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β0/β0 Genotype
With the pricing situation 'untenable' in Europe, bluebird will wind down its operations in the 'broken' market
Bluebird Bio nabs its 2nd gene therapy approval: The $3M Skysona
Articles with bluebird bio
bluebird bio Dedicates New Biomanufacturing Plant in Durham | North Carolina Biotechnology Center
bluebird bio Office Photos | Glassdoor
bluebird bio to Present at the 31st Annual Credit Suisse Healthcare Conference | Business Wire
Working at bluebird bio | Glassdoor
